Search Results - Nobuyo Higashi‐Kuwata
- Showing 1 - 6 results of 6
-
1
Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis by Nobuyo Higashi‐Kuwata, Masatoshi Jinnin, Takamitsu Makino, Satoshi Fukushima, Yuji Inoue, Faith C. Muchemwa, Yuji Yonemura, Yoshihiro Komohara, Motohiro Takeya, Hiroaki Mitsuya, Hironobu Ihn
Published 2010Artigo -
2
Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure–Activity Relationship, and X-ray Structural Studies by Arun K. Ghosh, Jakka Raghavaiah, Dana Shahabi, Monika Yadav, Brandon J. Anson, Emma K. Lendy, Shin-ichiro Hattori, Nobuyo Higashi‐Kuwata, Hiroaki Mitsuya, Andrew D. Mesecar
Published 2021Artigo -
3
Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma by Kenji Maeda, Nobuyo Higashi‐Kuwata, Noriko Kinoshita, Satoshi Kutsuna, K. Tsuchiya, Shin‐ichiro Hattori, Kouki Matsuda, Yuki Takamatsu, Hiroyuki Gatanaga, Shinichi Oka, Haruhito Sugiyama, Norio Ohmagari, Hiroaki Mitsuya
Published 2021Artigo -
4
4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus by Yuki Takamatsu, Yasuhito Tanaka, Satoru Kohgo, Shuko Murakami, Kamalendra Singh, Debananda Das, David Venzon, Masayuki Amano, Nobuyo Higashi‐Kuwata, Manabu Aoki, Nicole S. Delino, Sanae Hayashi, Satoru Takahashi, Yoshikazu Sukenaga, Kazuhiro Haraguchi, Stefan G. Sarafianos, Kenji Maeda, Hiroaki Mitsuya
Published 2015Artigo -
5
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency by Manabu Aoki, Hironori Hayashi, Kalapala Venkateswara Rao, Debananda Das, Nobuyo Higashi‐Kuwata, Haydar Bulut, Hiromi Aoki-Ogata, Yuki Takamatsu, Ravikiran S. Yedidi, David A. Davis, Shin-ichiro Hattori, Noriko Nishida, Kazuya Hasegawa, Nobutoki Takamune, Prasanth R. Nyalapatla, Heather L. Osswald, Hirofumi Jono, Hideyuki Saito, Robert Yarchoan, Shogo Misumi, Arun K. Ghosh, Hiroaki Mitsuya
Published 2017Artigo -
6
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication by Shin-ichiro Hattori, Nobuyo Higashi‐Kuwata, Hironori Hayashi, Srinivasa Rao Allu, Jakka Raghavaiah, Haydar Bulut, Debananda Das, Brandon J. Anson, Emma K. Lendy, Yuki Takamatsu, Nobutoki Takamune, Naoki Kishimoto, Kazutaka Murayama, Kazuya Hasegawa, Mi Li, David A. Davis, Eiichi Kodama, Robert Yarchoan, Alexander Wlodawer, Shogo Misumi, Andrew D. Mesecar, Arun K. Ghosh, Hiroaki Mitsuya
Published 2021Artigo
Search Tools:
Related Subjects
Biochemistry
Biology
Chemistry
In vitro
Medicine
Virology
Enzyme
Antibody
Coronavirus disease 2019 (COVID-19)
Disease
Immunology
Indole test
Infectious disease (medical specialty)
Pathology
Protease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Stereochemistry
Virus
Antiretroviral therapy
CD14
CD163
CD64
CD68
Convalescent plasma
Cytotoxicity
Drug resistance
Entecavir
Environmental health
Enzyme inhibitor
Flow cytometry